TP53 and cancer: This approach shows promise for the treatment of malignancies with mutational profiles that limit the efficacy of conventional FPs, such as p53 mutations [63], and so may be important for a personalized medicine approach to treatment since many anti-cancer drugs, including 5-FU, are relatively less effective towards p53 mutant cancer cells [64].